No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹2,697.6Prev. Close
₹2,697.6Turnover(Lac.)
₹445.58Day's High
₹2,878Day's Low
₹2,690.152 Week's High
₹3,00552 Week's Low
₹980Book Value
₹519.82Face Value
₹5Mkt Cap (₹ Cr.)
1,721.19P/E
40.09EPS
67.37Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 276.52 | 259.72 | 222.43 | 203.48 |
Net Worth | 279.61 | 262.81 | 225.52 | 206.57 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 318.66 | 258.18 | 152.18 | 113.65 |
yoy growth (%) | 23.42 | 69.65 | 33.89 | 13.97 |
Raw materials | -148.31 | -102.5 | -64.8 | -45.86 |
As % of sales | 46.54 | 39.7 | 42.58 | 40.35 |
Employee costs | -33.05 | -27.23 | -23.8 | -18.37 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 68.97 | 75.99 | 14.35 | 17.8 |
Depreciation | -7.67 | -7.39 | -7.26 | -4.56 |
Tax paid | -16.72 | -20.52 | -3.74 | -5.2 |
Working capital | 39.27 | 16.39 | 25.59 | -4.17 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.42 | 69.65 | 33.89 | 13.97 |
Op profit growth | -14.49 | 273.41 | -3.79 | -15.26 |
EBIT growth | -9.38 | 368.73 | -14.21 | -17.74 |
Net profit growth | -5.81 | 423.11 | -15.79 | -15.4 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 500.95 | 368.26 | 338.69 | 278.08 | 317.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 500.95 | 368.26 | 338.69 | 278.08 | 317.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 14.73 | 8.63 | 14.13 | 5.53 | 10.68 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.2 | 147.48 | 4,42,677.3 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,667 | 67.78 | 1,80,457.58 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,410.8 | 68.47 | 1,53,684.69 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,401 | 30.96 | 1,14,562.27 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,303.5 | 34.19 | 1,10,095.43 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Dhananjay N Mungale
ED / MD / Promoter
Rahul J Nachane
ED / WTD / CFO / Promoter
Rajesh N Lawande
Independent Non Exe. Director
Jayaram Sitaram
Independent Non Exe. Director
Ajita Nachane
Independent Non Exe. Director
Sarala Menon
Independent Non Exe. Director
S R Deo
Company Sec. & Compli. Officer
Shivam Gharat
301 E Square Subhash Road,
Vile Parle (East),
Maharashtra - 400057
Tel: +91-22-2663 6450
Website: http://www.nglfinechem.com
Email: info@nglfinechem.com
Shiv Shakti Indust,
Unit No 9 Lower Pare, 7 B J R Boricha Marg,
Mumbai-400011
Tel: 91-022-23016761
Website: www.purvashare.com
Email: busicomp@vsnl.com
Summary
NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Public Limited Company. The Company has got its registered of...
Read More
Reports by NGL Fine Chem Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.